Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Iron supplements help anemic children even if they have colds

22.01.2003


In a recent study, giving iron supplements to anemic children when they have a cold or other upper respiratory tract infection (URTI) significantly improved their iron status without increasing stomach upset or other side effects, says a Penn State nutritionist.



Dr. Namanjeet Ahluwalia, associate professor of nutrition and principle investigator on the research team, says, "Because of conflicting results from previous studies, physicians preferred to be cautious and generally withhold iron until a child was infection-free – which could delay the benefits of treatment if a child is iron deficient.

"Our study – the first controlled study in young children with recurrent URTI to date -- shows no increase in gastro-intestinal or other side effects from supplementation. In fact, children who received the iron supplement experienced 9 to 10 fewer sick days than those who did not. Those who did not receive supplementation were sick more often and for longer periods of time."


She adds, "Iron deficiency affects about 10 percent of U.S. infants and toddlers and is a leading health risk factor in high mortality, developing and developed countries. Our study shows there is no longer any reason to give correcting iron deficiency a back seat in children who have upper respiratory tract infections if iron deficiency is indicated."

The team’s study is detailed in a paper, "Iron Supplementation Improves Iron Status and Reduces Morbidity in Children With or Without Upper Respiratory Tract Infections; A Randomized Controlled Study in Colombo, Sri Lanka" which appears in the current (January) issue of the American Journal of Clinical Nutrition. The authors are Angela de Silva, a doctoral candidate at the University of Colombo whom Ahluwalia is co-advising; Dr. Sunethra Atukorala, professor of biochemistry at the University of Colombo; and Dr. Irangani Weerasinghe, a physician at the Lady Ridgeway Children’s Hospital in Colombo and Ahluwalia.

Nearly 500 children were recruited for the study from among the patients at the Outpatient Department of the Lady Ridgeway Children’s Hospital in Colombo, Sri Lanka, which is a non-fee, state-run hospital. Children with severe anemia, a history of other systemic diseases, chronic bronchial asthma, or chronic diarrhea were excluded from the study, and followed up with medical treatment.

Among the study participants with infections, 127 children were given supplements and 52 given a placebo or pills that did not contain iron. One hundred and thirty four children without infection were given iron and 50 given the placebo. All children who were still anemic at the end of the 8-week study period received supplements. The supplement was a tablet containing 60 mg of iron, the recommended daily dose.

Of the children with infections, those who received iron had 29 percent fewer upper respiratory episodes than those who received a placebo and had infectious episodes that were 40 percent less severe than those of the children who received placebos. Children who did not have iron deficiency but received iron anyway didn’t have an increase in colds or stomach upset versus those given placebo.

The authors write, "The higher mean number of illness-free days in the children who received iron than in those who received placebo suggests that iron supplementation is likely to improve the quality of life of these children and ensure better school attendance."

Barbara Hale | EurekAlert!
Further information:
http://www.psu.edu/

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

Camera on NASA's Lunar Orbiter survived 2014 meteoroid hit

29.05.2017 | Physics and Astronomy

Strathclyde-led research develops world's highest gain high-power laser amplifier

29.05.2017 | Physics and Astronomy

A 3-D look at the 2015 El Niño

29.05.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>